Quantitative pharmacology to support critical drug development decisions across non-clinical and clinical stages

Services

Non-Clinical PK/PD & Dose Justification

  • PK/PD model development and interpretation

  • Dose–response characterisation

  • Exposure and biomarker integration

  • Study design and optimisation input

Clinical Pharmacology & Development Support

  • SAD/MAD PK analysis and interpretation

  • Dose escalation strategy support

  • Variability and covariate assessment

  • Early study design input

  • Clinical trial analysis across later-stage development programmes

  • Interpretation of exposure–response and dose optimisation in clinical settings

Translational Modelling

  • First-in-human dose prediction

  • Cross-species scaling and translation

  • Mechanistic and semi-mechanistic modelling

  • Scenario analysis for development decisions

Expertise & Approach

Therapeutic & Modality Experience

  • Oncology & other therapeutic areas

  • Small molecules and biologics

  • ADCs and bispecific antibodies

  • Translational pharmacology (including regulatory contexts such as the FDA Animal Rule)

Client Engagement Style

  • Project-based quantitative support

  • Strategic modelling input across programmes

  • Close collaboration with internal teams as required

Questions before getting started?

Get in touch.